About the client Cytura Therapeutics is an early-stage pharmaceutical company based in the Netherlands that develops novel drugs targeting genomic instability in cancer. For their project with BioLizard, Cytura wanted to know whether treatment of human B cells...
Mdxhealth is a front runner in epigenetic research with a proven track record of identifying, developing, validating and delivering molecular diagnostic assays. They provide functional genomic data that can be used for personalised cancer risk assessment, with...
